Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2159
https://www.valueinhealthjournal.com/article/S1098-3015(16)33525-2/fulltext
Title :
Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33525-2&doi=10.1016/j.jval.2016.09.2159
First page :
A723
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2045